Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Greenwich LifeSciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 30 | 36 | +6 |
| Shares | 810.8K | 815.7K | +4.91K (+0.6%) |
| Value | $36.4M | $31.9M | −$4.52M (−12.4%) |
New holders (7)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 28,229 | $1.13M | 0.00% |
| Millennium Management LLC | 15,098 | $590.0K | 0.00% |
| Tibra Equities Europe Ltd | 12,700 | $496.0K | 0.76% |
| Old Mission Capital LLC | 7,358 | $287.0K | 0.01% |
| Ameriprise Financial Inc | 6,299 | $246.0K | 0.00% |
| Dorsey Wright & Associates | 1,118 | $44.0K | 0.01% |
| Newbridge Financial Services Group, Inc. | 500 | $20.0K | 0.01% |
Sold out (1)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| The PNC Financial Services Group, Inc. | 100 | $4.00K |